Physician profile
Larry E Puls
NPI 1225096340
$2,246.66
in general payments reported to CMS, 2019-2025
17 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $192 · 2021: $214 · 2022: $416 · 2023: $559 · 2024: $145 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Education: $64.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.07 |
| Education | $64.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $518.38 | 2020-2025 | Keytruda, Lynparza, Lenvima |
| Glaxosmithkline, LLC. | $238.53 | 2023-2024 | Jemperli, Zejula |
| Myriad Genetic Laboratories, INC. | $229.39 | 2021-2025 | Myrisk |
| Astrazeneca Pharmaceuticals Lp | $170.66 | 2019-2025 | Lynparza |
| Eisai INC. | $168.14 | 2022-2023 | |
| Clovis Oncology, INC. | $118.36 | 2020 | |
| Baxter Healthcare | $116.41 | 2023-2024 | Adept, Perclot |
| Daiichi Sankyo INC. | $114.80 | 2025 | Enhertu |
| Amgen INC. | $109.26 | 2019 | |
| Puma Biotechnology, INC. | $94.35 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $90.79 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $70.03 | 2022 | |
| Novartis Pharmaceuticals Corporation | $63.60 | 2023-2024 | |
| Incyte Corporation | $50.86 | 2019-2020 | |
| Abbvie INC. | $47.66 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $26.89 | 2024 | Tivdak |
| Sanara Medtech INC. | $18.55 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Puls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.